31st National Medicinal Chemistry Symposium Home
programregisterpostersactivitiestravelsponsorscontact

PROGRAM

Sunday, June 15

11:00 AM

Registration

 

Alumni Hall

2:00 - 2:15 PM

Opening Remarks

Symposium Chair:
Barry Gold, University of Pittsburgh

Program Chairs:
Mark Murcko, Vertex Pharmaceuticals
Peter Wipf, University of Pittsburgh


Alumni Hall

2:10 - 5:30 PM

 

2:15 PM


3:05 PM


3:55 PM

4:05 PM


4:55 PM

Oral Session 1
Hepatitis C

Session Chair: Robert Schooley, University of California, San Diego

Challenges of HCV Clinical Development
Robert Schooley, University of California, San Diego

Protease Inhibitors
Milind Deshpande. Achillion

Refreshment Break

Nucleoside Inhibitors
Steven Carroll, Merck Research Laboratories

Non-nucleoside Inhibitors
Rolf Wagner, Abbott

 

Alumni Hall

6:00 - 7:30 PM

Welcome Reception

Cathedral of Learning

7:45 – 9:45 PM



7:50 PM




8:20 PM


8:50 PM




9:20 PM

Oral Session 2
Virtual Library Design and Screening

Session Chair: Patrick Walters, Vertex Pharmaceuticals

Numerical Characterization of Structure-Activity Relationships from a Medicinal Chemist's Point of View
Rajarshi Guha, Indiana University

QSAR: Where Statistics and Chemistry Collide
Robert Sheridan, Merck

Rule of 5, Rules of Thumb and Physicochemical Properties: How Do We Apply Them and Are There Rules At All?
Franco Lombardo, Novartis

Virtual Screening Enrichment Studies: The Devil is in the Details
Andrew C. Good, Bristol-Myers Squibb

 

Alumni Hall

spacer

Monday, June 16

8:30 AM


Welcome Remarks by Arthur S. Levine, M.D.
Senior Vice Chancellor for Health Sciences and Dean,
School of Medicine, University of Pittsburgh

 

 

8:35 AM - 12:30 PM


8:40 AM




9:30 AM



10:20 AM


10:40 AM


11:30 AM

Oral Session 3
Molecular Approaches to
Cancer Therapy
Session Chair: Robert Abraham, Wyeth Research

Cancer Therapeutic Modalities with Kinase Irreversible Inhibitors
Tarek S. Mansour, Wyeth

Apoptosis Based Anti-Cancer Therapies: A Fragment-Based Approach to Lead Design and Optimization
Maurizio Pellecchia, Burnham Institute

Refreshment Break

Drugging the PI3-Kinase Family
Zachary Knight, Rockefeller Institute

A Global Perspective of Small Molecule-Biochemical Network Interactions
Steve Michnick, University of Montreal

 

Alumni Hall

12:20 - 1:50 PM

Lunch

 

Alumni Hall

2:00 PM - 5:30 PM

 


2:05 PM




2:55 PM


3:45 PM


4:00 PM

 

4:50 PM

Oral Session 4
Targeting Transcriptional Control Via Secondary DNA Structures
Session Chair: Laurence Hurley, University of Arizona

Genome-Wide Regulatory Role of G-Quadruplex DNA as Conserved Cis-Regulatory Motifs
Shantanu Chowdhury, Institute of Genomics and Integrative Biology, India

Structural Studies of G-Quadruplexes Formed in Promoters of Oncogenes
Danzhou Yang, University of Arizona

Refreshment Break

The Function and Chemical Biology of Nucleic Acid G-Quadruplexes
Shankar Balasubramanian, University of Cambridge

Small Molecule Targeting of Transcriptional Control and the Origins of Quarfloxacin, the First G-Quadruplex-Interactive Compound to Reach the Clinic
Laurence Hurley, University of Arizona

 

Alumni Hall

6:00 - 7:45 PM

Poster Session A
Posters 101 - 147

 

Alumni Hall

Tuesday, June 17

8:30 AM - 12:30 PM


8:35 AM


9:25 AM


10:15 AM


10:35 AM



11:25 AM

Oral Session 5
Inflammation/Immunology
Session Chair: Robert Zamboni, Merck Frosst Research

The Discovery of CCR2 Antagonist MK-812
Lihu Yang, Merck Research Laboratories

Structure-Based Design Potent and Highly Selective p38 MAP Kinase Inhibitors
Andrew S. Tasker, Amgen Inc.

Refreshment Break

Substitued Pheranthrene Imidazoles as Potent, Selective, and Orally Active mPGES-1 Inhibitors
Bernard Cote, Merck Frosst Research

Selective Inhibitors of Classic and Novel PKC Isotypes as Immunomodulators
Maurice J. van Els, Novartis

 

Alumni Hall

12:35 - 12:50 PM

Box Lunch

 

Alumni Hall

Afternoon Open

Open Time / Optional Tours

 

 

8:00 – 10:00 PM

Poster Session B
Posters 201 - 244

 

Alumni Hall

Wednesday, June 18

8:00 AM - 12:00 PM


8:05 AM


8:40 AM



9:15 AM

 

 


9:50 AM

10:05 AM

 


10:40 AM




11:15 AM

 

11:50 AM

Oral Session 6
Late-Breaking/First Time Disclosures
Session Chair: William Greenlee (Schering-Plough)

Designing Oral gp120 Inhibitors for the Treatment of HIV
Don Middleton, Pfizer

Discovery of a Unique Class of c-Met Inhibitors for the Treatment of Cancer
Jason Katz, Merck

Discovery of 1-[9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic acid amine hydrochloride (CP-945,598), a Novel, Potent and Selective Cannabinoid CB1 Receptor Antagonist
David Griffith, Pfizer

Refreshment Break

Simulating the Release of Endogenous PTH--A New Therapeutic Approach for the Treatment of Established Osteoporosis
Leo Widler, Novartis Institutes of Biomedical
Research

TG100801: A Topically Administered Kinase Inhibitor for the Treatment of Age Related Macular Degeneration
Moorthy S. S. Palanki TargeGen

Preclinical Characterization of a Selective Glucocorticoid Receptor Modulator
Michael Coghlan, Eli Lilly

Synthesis and Activity of 1-(3-amino-2-hydroxy-1-phenylpropyl)indolin-2-ones: Discovery of Selective Norepinephrine Reuptake Inhibitor WAY-315193 (NRI-193)
Casey McComas, Wyeth

 

Alumni Hall

12:10 -  2:00 PM

Lunch

 

Alumni Hall

1:50 PM - 5:30 PM

 

 

1:55 PM

2:00 PM

 


2:30 PM

 


3:15 PM



3:30 PM

3:35 PM

 



4:20 PM

4:25 PM

 

4:55 PM

Oral Session 7
ACS Medicinal Chemistry Awards
Session Chair: Donald Abraham, Virginia Commonwealth University

2008 IUPAC Richter Award

Introduction to IUPAC Richter Award

High-Resolution Structures of HIV-1 RT/Rilpivirine Complexes: Strategic Flexibility Explains Potency Against Resistance Mutations
Edward Arnold, Rutgers University

IUPAC Richter Award Lecture: Progress in the Development of Non-nucleoside Reverse Transcriptase Inhibitors: From Tibo to Rilpivirine
Award Winner: Jan Heeres

Refreshment Break

2008 OBC Award

Introduction to OBC Award

OBC Award Lecture: DNA-Osmium Complex for DNA Methylation Analysis
Award Winner: Akimitsu Okamoto, RIKEN,
  Advanced Science Institute


2008 Division of Medicinal Chemistry Award

Introduction to Division of Medicinal Chemistry Award

Potent Chimeric NRTI-NNRTI Bifunctional Inhibitors of HIV-1 Reverse Transcriptase
Karen Anderson, Yale University

2008 Division of Medicinal Chemistry Award: Search for Selective Androgen Receptor Modulators (SARMs)
Award Winner: Duane D. Miller, University of
  Tennessee
at Mephis


Alumni Hall

6:30 - 10:00 PM

ACS Division of Medicinal Chemistry Awards Banquet

Carnegie Museum

Thursday, June 19

8:30 AM - 12:00 PM

 

8:35 AM



9:20 AM


10:05 AM

10:20 AM

 


11:05 AM

Oral Session 8
Biomarkers/PET
Session Chair: Donna Huryn, University of Pittsburgh

Click Chemistry-Based Development of New PET Imaging Tracers
Hartmuth Kolb, Siemens Biomarkers

PET Imaging in Drug Development
Terence Hamill, Merck

Refreshment Break

The Development and Application of Pittsburgh Compound B to Human Amyloid Imaging
William E.Klunk & Chester A.Mathis, University of Pittsburgh

Designing Xe-129 Biosensors for In Vivo Magnetic Resonance Imaging
Ivan J. Dmochowski, University of Pennsylvania

 

Alumni Hall

12:00 PM

Box Lunch

 

Alumni Hall


Conference Closes